refractory intrahepatic cholangiocarcinoma
Conditions
Interventions
Intermediate and advanced intrahepatic cholangiocarcinoma:CalliSpheres Microspheres Loaded with Sensitive Chemotherapy Drugs for Arterial Embolization
Sponsors
Shanghai International Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Intermediate-advanced intrahepatic cholangiocytic cells diagnosed by clinical or imaging or pathological diagnosis; 2. The primary and metastatic lesions cannot be surgically removed by surgery; 3. Child-Pugh classification of liver function is A, B; 4. The main portal vein is not completely blocked, or although the main portal vein is completely blocked, there are many compensatory collateral vessels in the hepatic portal.
Exclusion criteria
Exclusion criteria: 1. Child-Pugh classification of liver function is C; 2. The coagulation function is severely decreased and cannot be corrected; 3. The main portal vein is completely blocked by tumor thrombus, with few collateral vessels or portal hypertension with reverse blood flow; 4. Co-infections, such as liver abscesses, cannot be treated at the same time; The tumor has widespread metastases throughout the body, and the estimated patient survival time is less than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ORR; | — |
Secondary
| Measure | Time frame |
|---|---|
| DCR;AE; | — |
Countries
China
Contacts
Public ContactHongwei Hua
Shanghai International Medical Center
Outcome results
None listed